For: | Giannini EG, Cucchetti A, Erroi V, Garuti F, Odaldi F, Trevisani F. Surveillance for early diagnosis of hepatocellular carcinoma: How best to do it? World J Gastroenterol 2013; 19(47): 8808-8821 [PMID: 24379604 DOI: 10.3748/wjg.v19.i47.8808] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i47/8808.htm |
Number | Citing Articles |
1 |
Matteo Renzulli, Emanuela Giampalma. Hepatocellular Carcinoma: Imaging Advances in 2024 with a Focus on Magnetic Resonance Imaging. Current Oncology 2025; 32(1): 40 doi: 10.3390/curroncol32010040
|
2 |
Munkhzul Otgonsuren, Linda Henry, Sharon Hunt, Chapy Venkatesan, Alita Mishra, Zobair M. Younossi. Resource Utilization and Survival Among Medicare Patients with Advanced Liver Disease. Digestive Diseases and Sciences 2015; 60(2): 320 doi: 10.1007/s10620-014-3318-9
|
3 |
Teerapat Ungtrakul, Chulabhorn Mahidol, Pattra Chun-on, Charlie Laohapand, Surachate Siripongsakun, Akeanong Worakitsitisatorn, Sirachat Vidhayakorn, Wariya Boonchuay, Jiraporn Dechma, Gaidganok Sornsamdang, Kamonwan Soonklang, Tassanee Sriprayoon, Tawesak Tanwandee, Chirayu U Auewarakul. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area. World Journal of Gastroenterology 2016; 22(34): 7806-7812 doi: 10.3748/wjg.v22.i34.7806
|
4 |
Laura Paneghetti, Andrea Gallotta, Chiara Parrozzani, Giorgio Fassina. Biomarkers development for early detection of cancer: Reducing the burden of cancer in the ageing society. The EuroBiotech Journal 2018; 2(1): 30 doi: 10.2478/ebtj-2018-0005
|
5 |
Edoardo G. Giannini, Fabio Farinati, Francesca Ciccarese, Anna Pecorelli, Gian Lodovico Rapaccini, Mariella Di Marco, Luisa Benvegnù, Eugenio Caturelli, Marco Zoli, Franco Borzio, Maria Chiaramonte, Franco Trevisani. Prognosis of untreated hepatocellular carcinoma. Hepatology 2015; 61(1): 184 doi: 10.1002/hep.27443
|
6 |
Maria Guarino, Alessandro Cucchetti, Giuseppina Pontillo, Fabio Farinati, Francesca Benevento, Gian Ludovico Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Sacco Rodolfo, Giuseppe Cabibbo, Fabio Marra, Andrea Mega, Antonio Gasbarrini, Gianluca Svegliati‐Baroni, Francesco Giuseppe Foschi, Gabriele Missale, Alberto Masotto, Gerardo Nardone, Giovanni Raimondo, Francesco Azzaroli, Gianpaolo Vidili, Filippo Oliveri, Franco Trevisani, Edoardo G. Giannini, Filomena Morisco. Pattern of macrovascular invasion in hepatocellular carcinoma. European Journal of Clinical Investigation 2021; 51(7) doi: 10.1111/eci.13542
|
7 |
Emanuel Gonçalves, Maria Gonçalves-Reis, José B. Pereira-Leal, Joana Cardoso. DNA methylation fingerprint of hepatocellular carcinoma from tissue and liquid biopsies. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-15058-0
|
8 |
Ines Dhifallah, Marwa Khedhiri, Anissa Chouikha, Ghassen Kharroubi, Walid Hammami, Amel Sadraoui, Mohamed Msaddek Azzouz, Nadia Maamouri, Tahar Khalfallah, Henda Triki, Pascal Pineau, Olfa Bahri. Hepatitis viruses take advantage of traditional practices to increase the burden of hepatocellular carcinoma in Tunisia. Archives of Virology 2020; 165(1): 33 doi: 10.1007/s00705-019-04440-5
|
9 |
Maxime Ronot, Romain Pommier, Marco Dioguardi Burgio, Yvonne Purcell, Pierre Nahon, Valérie Vilgrain. Hepatocellular carcinoma surveillance with ultrasound—cost-effectiveness, high-risk populations, uptake. The British Journal of Radiology 2018; 91(1090): 20170436 doi: 10.1259/bjr.20170436
|
10 |
Francesca Garuti, Andrea Neri, Francesca Avanzato, Annagiulia Gramenzi, Davide Rampoldi, Paola Rucci, Fabio Farinati, Edoardo G. Giannini, Fabio Piscaglia, Gian Ludovico Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Rodolfo Sacco, Giuseppe Cabibbo, Fabio Marra, Andrea Mega, Filomena Morisco, Antonio Gasbarrini, Gianluca Svegliati‐Baroni, Francesco G. Foschi, Gabriele Missale, Alberto Masotto, Gerardo Nardone, Giovanni Raimondo, Francesco Azzaroli, Gianpaolo Vidili, Maurizia R. Brunetto, Franco Trevisani. The changing scenario of hepatocellular carcinoma in Italy: an update. Liver International 2021; 41(3): 585 doi: 10.1111/liv.14735
|
11 |
Arshi Khanam, Shyam Kottilil. New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter?. International Journal of Molecular Sciences 2022; 24(1): 437 doi: 10.3390/ijms24010437
|
12 |
Andrea Marcellusi, Raffaella Viti, Francesco Damele, Calogero Cammm, Gloria Taliani, Francesco Saverio Mennini. Early Treatment in HCV: Is it a Cost-Effective Option from the Italian Perspective?. SSRN Electronic Journal 2016; doi: 10.2139/ssrn.2753692
|
13 |
Bernardo Stefanini, Matteo Tonnini, Ilaria Serio, Matteo Renzulli, Francesco Tovoli. Surveillance for hepatocellular carcinoma: current status and future perspectives for improvement. Expert Review of Anticancer Therapy 2022; 22(4): 371 doi: 10.1080/14737140.2022.2052276
|
14 |
Derek J. Erstad, Bryan C. Fuchs, Kenneth K. Tanabe. Molecular signatures in hepatocellular carcinoma: A step toward rationally designed cancer therapy. Cancer 2018; 124(15): 3084 doi: 10.1002/cncr.31257
|
15 |
Edoardo G. Giannini, Costanza De Maria, Mattia Crespi, Maria Giulia Demarzo, Valentina Fazio, Alessandro Grasso, Francesco Torre, Giorgia Bodini, Elisa Marabotto, Manuele Furnari. Course of oesophageal varices and performance of noninvasive predictors following Hepatitis C Virus clearance in compensated advanced chronic liver disease. European Journal of Clinical Investigation 2020; 50(5) doi: 10.1111/eci.13231
|
16 |
Filippo Pelizzaro, Alessandro Vitale, Anna Sartori, Andrea Vieno, Barbara Penzo, Francesco Russo, Anna Frigo, Edoardo Giannini, Manuela Piccinnu, Gian Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Rodolfo Sacco, Ciro Celsa, Fabio Marra, Andrea Mega, Maria Guarino, Antonio Gasbarrini, Gianluca Svegliati-Baroni, Francesco Foschi, Andrea Olivani, Alberto Masotto, Pietro Coccoli, Giovanni Raimondo, Francesco Azzaroli, Gianpaolo Vidili, Maurizia Brunetto, Franco Trevisani, Fabio Farinati. Surveillance as Determinant of Long-Term Survival in Non-Transplanted Hepatocellular Carcinoma Patients. Cancers 2021; 13(4): 897 doi: 10.3390/cancers13040897
|
17 |
Giacomo Zanus, Giovanni Tagliente, Serena Rossi, Alessandro Bonis, Mattia Zambon, Michele Scopelliti, Marco Brizzolari, Ugo Grossi, Maurizio Romano, Michele Finotti. Pulsed Microwave Liver Ablation: An Additional Tool to Treat Hepatocellular Carcinoma. Cancers 2022; 14(3): 748 doi: 10.3390/cancers14030748
|
18 |
Matea Majerović, Mislav Jelaković, Marina Premužić, Ivana Knežević Štromar, Davor Radić, Marko Mance, Stjepko Pleština, Rajko Ostojić, Nadan Rustemović, Zeljko Krznarić. Hepatocellular Carcinoma Surveillance—Experience from Croatian Referral Centre for Chronic Liver Diseases. Journal of Gastrointestinal Cancer 2019; 50(1): 48 doi: 10.1007/s12029-017-0011-1
|
19 |
Maria Corina Plaz Torres, Giorgia Bodini, Manuele Furnari, Elisa Marabotto, Patrizia Zentilin, Mario Strazzabosco, Edoardo G. Giannini. Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?. Cancers 2020; 12(6): 1422 doi: 10.3390/cancers12061422
|
20 |
Edoardo G Giannini, Alessandro Moscatelli, Gaia Pellegatta, Alessandro Vitale, Fabio Farinati, Francesca Ciccarese, Fabio Piscaglia, Gian Lodovico Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Franco Borzio, Giuseppe Cabibbo, Martina Felder, Rodolfo Sacco, Filomena Morisco, Gabriele Missale, Francesco Giuseppe Foschi, Antonio Gasbarrini, Gianluca Svegliati Baroni, Roberto Virdone, Alberto Masotto, Franco Trevisani. Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma. American Journal of Gastroenterology 2016; 111(1): 70 doi: 10.1038/ajg.2015.389
|
21 |
Jui-Kun Chiang, Lin Chih-Wen, Yee-Hsin Kao. Effect of ultrasonography surveillance in patients with liver cancer: a population-based longitudinal study. BMJ Open 2017; 7(6): e015936 doi: 10.1136/bmjopen-2017-015936
|
22 |
Pannapa Sangmala, Usa Chaikledkaew, Tawesak Tanwandee, Petcharat Pongchareonsuk. Economic Evaluation and Budget Impact Analysis of the Surveillance Program for Hepatocellular Carcinoma in Thai Chronic Hepatitis B Patients. Asian Pacific Journal of Cancer Prevention 2014; 15(20): 8993 doi: 10.7314/APJCP.2014.15.20.8993
|
23 |
Andrea Pasta, Giulia Pieri, Maria Corina Plaz Torres, Franco Trevisani, Edoardo G. Giannini. Hepatocellular carcinoma in patients with autoimmune hepatitis. Journal of Hepatology 2024; 81(3): e131 doi: 10.1016/j.jhep.2024.03.025
|
24 |
Edoardo G. Giannini, Giulia Pieri, Sara Labanca, Maria Corina Plaz Torres, Antonio Gasbarrini, Elisabetta Biasini, Claudia Campani, Nora Cazzagon, Francesco Giuseppe Foschi, Andrea Mega, Alberto Masotto, Giovanni Raimondo, Gian Ludovico Rapaccini, Rodolfo Sacco, Eugenio Caturelli, Maria Guarino, Francesco Tovoli, Gianpaolo Vidili, Maurizia Rossana Brunetto, Gerardo Nardone, Gianluca Svegliati-Baroni, Donatella Magalotti, Francesco Azzaroli, Giuseppe Cabibbo, Maria Di Marco, Angelo Sangiovanni, Franco Trevisani, Maurizio Biselli, Paolo Caraceni, Annagiulia Gramenzi, Francesca Benevento, Alessandro Granito, Luca Muratori, Fabio Piscaglia, Federica Bertellini, Fabio Farinati, Giorgio Palano, Filippo Pelizzaro, Barbara Penzo, Elisa Pinto, Gloria Allegrini, Calogero Cammà, Ciro Celsa, Paolo Giuffrida, Caterina Stornello, Mauro Grova, Carmelo Marco Giacchetto, Gabriele Rancatore, Maria Vittoria Grassini, Valentina Adotti, Stefano Gitto, Fabio Marra, Martina Rosi, Vittoria Bevilacqua, Alberto Borghi, Andrea Casadei Gardini, Fabio Conti, Lucia Napoli, Marco Domenicali, Maria Teresa Migliano, Nicoletta de Matthaeis, Francesca Romana Ponziani, Andrea Olivani, Gabriele Missale, Valentina Cossiga, Mario Capasso, Filomena Morisco, Ester Marina Cela, Antonio Facciorusso, Valentina Lauria, Giorgia Ghittoni, Giorgio Pelecca, Fabrizio Chegai, Fabio Coratella, Mariano Ortenzi, Serena Dell'Isola, Maria Stella Franzè, Carlo Saitta, Assunta Sauchella, Elton Dajti, Federico Ravaioli, Filippo Oliveri, Gabriele Ricco, Veronica Romagnoli, Alessandro Inno, Fabiana Marchetti, Pietro Coccoli, Antonio Malerba, Alberta Cappelli, Rita Golfieri, Cristina Mosconi, Matteo Renzulli. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma. Digestive and Liver Disease 2022; 54(9): 1215 doi: 10.1016/j.dld.2022.03.002
|
25 |
Thanh Hai Phan, Van Thien Chi Nguyen, Thu Thuy Thi Pham, Van-Chu Nguyen, Tan Dat Ho, Thi Mong Quynh Pham, Thanh-Huong Tran, Thanh Dat Nguyen, Nguyen Duy Khang Le, Trong-Hieu Nguyen, Minh-Long Duong, Hoai-Phuong Thi Bach, Van-Vu Kim, The-Anh Pham, Bao Toan Nguyen, Thanh Nhan Vo Nguyen, Thanh Dang Nguyen, Dung Thai Bieu Phu, Boi Hoan Huu Phan, Duy-Sinh Nguyen, Dinh-Kiet Truong, Thanh-Thuy Thi Do, Hoa Giang, Hoai-Nghia Nguyen, Minh-Duy Phan, Le Son Tran. Circulating DNA Methylation Profile Improves the Accuracy of Serum Biomarkers for the Detection Of Nonmetastatic Hepatocellular Carcinoma. Future Oncology 2022; 18(39): 4399 doi: 10.2217/fon-2022-1218
|
26 |
Moon Hyung Choi, Seung Eun Jung, Joon‐Il Choi, Woo Kyoung Jeong, Hyun Cheol Kim, Yongsoo Kim, Yeol Kim, Boyoung Park. Quality Management of Ultrasound Surveillance for Hepatocellular Carcinoma Under the Korean National Cancer Screening Program. Journal of Ultrasound in Medicine 2018; 37(1): 245 doi: 10.1002/jum.14339
|
27 |
Nicole Harris, Alexandra Gorelik, Robert N Gibson. Targeted ultrasound of the liver: Impact on scanning time of a new approach in chronic liver disease. Journal of Medical Imaging and Radiation Oncology 2017; 61(4): 448 doi: 10.1111/1754-9485.12595
|
28 |
Kaitlyn Kennedy, Susan M. Graham, Nayan Arora, Margaret C. Shuhart, H. Nina Kim, Isabelle Chemin. Hepatocellular carcinoma among US and non-US-born patients with chronic hepatitis B: Risk factors and age at diagnosis. PLOS ONE 2018; 13(9): e0204031 doi: 10.1371/journal.pone.0204031
|
29 |
Francesca Romana Ponziani, Edoardo G. Giannini, Quirino Lai. Machine learning and biomarkers in hepatocellular carcinoma: The future is now. Liver Cancer International 2022; 3(3): 111 doi: 10.1002/lci2.67
|
30 |
Gurjeet Dulku, Ravinder Dhillon, Mark Goodwin, Wendy Cheng, Nick Kontorinis, Richard Mendelson. The role of imaging in the surveillance and diagnosis of hepatocellular cancer. Journal of Medical Imaging and Radiation Oncology 2017; 61(2): 171 doi: 10.1111/1754-9485.12568
|
31 |
Edoardo G. Giannini, Franco Trevisani. Screening for Hepatocellular Carcinoma in Chronic Liver Disease. Annals of Internal Medicine 2015; 162(3): 239 doi: 10.7326/L15-5049-2
|
32 |
Feiyu Chen, Zhangfeng Zhong, Hor-Yue Tan, Ning Wang, Yibin Feng. The Significance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma: Real-Time Monitoring and Moving Targets for Cancer Therapy. Cancers 2020; 12(7): 1734 doi: 10.3390/cancers12071734
|
33 |
Edoardo G. Giannini, Franco Trevisani. Accuracy of α-Fetoprotein Measurement in Detection of Hepatocellular Carcinoma—1 More Nail in the Coffin. Clinical Gastroenterology and Hepatology 2014; 12(12): 2138 doi: 10.1016/j.cgh.2014.07.006
|
34 |
Wu Zhang, Cheng-Guang Zhao, Hong-Yu Sun, Wei-E Zheng, Hua Chen. Expression Characteristics of KAI1 and Vascular Endothelial Growth Factor and Their Diagnostic Value for Hepatocellular Carcinoma. Gut and Liver 2014; 8(5): 536 doi: 10.5009/gnl13331
|
35 |
Stephen Bloom, William Kemp, Amanda Nicoll, Stuart K. Roberts, Paul Gow, Anouk Dev, Sally Bell, Siddharth Sood, Ian Kronborg, Virginia Knight, Diana Lewis, John Lubel. Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis C. Journal of Hepatology 2018; 69(3): 575 doi: 10.1016/j.jhep.2018.04.013
|
36 |
N. Semmo, T. Weber, J. R. Idle, D. Beyoğlu. Metabolomics reveals that aldose reductase activity due to AKR1B10 is upregulated in hepatitis C virus infection. Journal of Viral Hepatitis 2015; 22(7): 617 doi: 10.1111/jvh.12376
|
37 |
Suzanne Sheppard‐Law, Iryna Zablotska‐Manos, Melissa Kermeen, Susan Holdaway, Alice Lee, Jacob George, Amany Zekry, Lisa Maher. Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus‐related carcinoma and prescribed anti‐viral therapy. Journal of Clinical Nursing 2018; 27(13-14): 2673 doi: 10.1111/jocn.14367
|
38 |
Otilia Mårdh, Chantal Quinten, Andrew J. Amato-Gauci, Erika Duffell. Mortality from liver diseases attributable to hepatitis B and C in the EU/EEA – descriptive analysis and estimation of 2015 baseline. Infectious Diseases 2020; 52(9): 625 doi: 10.1080/23744235.2020.1766104
|
39 |
Newsha Nikzad, David Fuentes, Millicent Roach, Tasadduk Chowdhury, Matthew Cagley, Mohamed Badawy, Ahmed Elkhesen, Manal Hassan, Khaled Elsayes, Laura Beretta, Eugene Koay, Prasun Jalal. Enhancement Pattern Mapping for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis. Journal of Hepatocellular Carcinoma 2024; : 595 doi: 10.2147/JHC.S449996
|
40 |
Andrea Marcellusi, Raffaella Viti, Francesco Damele, Calogero Cammà, Gloria Taliani, Francesco Saverio Mennini. Early Treatment in HCV: Is it a Cost-Utility Option from the Italian Perspective?. Clinical Drug Investigation 2016; 36(8): 661 doi: 10.1007/s40261-016-0414-y
|
41 |
Christina Schraml, Sascha Kaufmann, Hansjoerg Rempp, Roland Syha, Dominik Ketelsen, Mike Notohamiprodjo, Konstantin Nikolaou. Imaging of HCC—Current State of the Art. Diagnostics 2015; 5(4): 513 doi: 10.3390/diagnostics5040513
|
42 |
Paul Martin, Daryl T.-Y. Lau, Mindie H. Nguyen, Harry L.A. Janssen, Douglas T. Dieterich, Marion G. Peters, Ira M. Jacobson. A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update. Clinical Gastroenterology and Hepatology 2015; 13(12): 2071 doi: 10.1016/j.cgh.2015.07.007
|
43 |
Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Kwang-Hyub Han, Do Young Kim. Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis. Scandinavian Journal of Gastroenterology 2019; 54(10): 1283 doi: 10.1080/00365521.2019.1673478
|
44 |
Soroosh Sabeti, Redouane Ternifi, Nicholas B. Larson, Michael C. Olson, Thomas D. Atwell, Mostafa Fatemi, Azra Alizad. Morphometric analysis of tumor microvessels for detection of hepatocellular carcinoma using contrast-free ultrasound imaging: A feasibility study. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1121664
|
45 |
Rui Deng, Jibin Wu, Baokang Zhu, Gaoqing Song, Tao Zhou, Musheng Yang, Lingling Pan, Jian Wang, Xuan Zou, Ziquan Lv, Xiaobao Jin, Yinghua Xu, Xuemei Lu, Shuiqing Gui. Engineered exosomes loaded with M1–8 peptide for targeted therapy of hepatocellular carcinoma. Applied Materials Today 2024; 37: 102071 doi: 10.1016/j.apmt.2024.102071
|
46 |
Laura Bucci, Francesca Garuti, Barbara Lenzi, Anna Pecorelli, Fabio Farinati, Edoardo G. Giannini, Alessandro Granito, Francesca Ciccarese, Gian Lodovico Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Franco Borzio, Rodolfo Sacco, Calogero Cammà, Roberto Virdone, Fabio Marra, Martina Felder, Filomena Morisco, Luisa Benvegnù, Antonio Gasbarrini, Gianluca Svegliati‐Baroni, Francesco Giuseppe Foschi, Gabriele Missale, Alberto Masotto, Gerardo Nardone, Antonio Colecchia, Mauro Bernardi, Franco Trevisani. The evolutionary scenario of hepatocellular carcinoma in Italy: an update. Liver International 2017; 37(2): 259 doi: 10.1111/liv.13204
|
47 |
E. G. Giannini. Editorial: a step forward in refining prognostication for patients with HIV‐associated hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2018; 47(1): 133 doi: 10.1111/apt.14374
|
48 |
Edoardo G. Giannini. Improving prognosis of patients with very early hepatocellular carcinoma: How far are we going?. Digestive and Liver Disease 2021; 53(2): 143 doi: 10.1016/j.dld.2020.11.006
|
49 |
Edoardo Giovanni Giannini, Laura Bucci, Francesca Garuti, Matteo Brunacci, Barbara Lenzi, Matteo Valente, Eugenio Caturelli, Giuseppe Cabibbo, Fabio Piscaglia, Roberto Virdone, Martina Felder, Francesca Ciccarese, Francesco Giuseppe Foschi, Rodolfo Sacco, Gianluca Svegliati Baroni, Fabio Farinati, Gian Lodovico Rapaccini, Andrea Olivani, Antonio Gasbarrini, Maria Di Marco, Filomena Morisco, Marco Zoli, Alberto Masotto, Franco Borzio, Luisa Benvegnù, Fabio Marra, Antonio Colecchia, Gerardo Nardone, Mauro Bernardi, Franco Trevisani. Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice. Hepatology 2018; 67(5): 1784 doi: 10.1002/hep.29668
|
50 |
Agostino Colli, Tin Nadarevic, Damir Miletic, Vanja Giljaca, Mirella Fraquelli, Davor Štimac, Giovanni Casazza. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database of Systematic Reviews 2021; 2021(4) doi: 10.1002/14651858.CD013346.pub2
|
51 |
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes. Cancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821
|
52 |
Sarah Augustine. Capsule Commentary on Larochelle et al., Reducing Excess Biomarker Testing at an Academic Medical Center. Journal of General Internal Medicine 2014; 29(11): 1526 doi: 10.1007/s11606-014-2967-x
|
53 |
Naik Vietti Violi, Sara Lewis, Stefanie Hectors, Daniela Said, Bachir Taouli. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; : 71 doi: 10.1007/978-3-030-21540-8_4
|
54 |
M Biselli, F Conti, A Gramenzi, M Frigerio, A Cucchetti, G Fatti, M D'Angelo, M Dall'Agata, E G Giannini, F Farinati, F Ciccarese, P Andreone, M Bernardi, F Trevisani. A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis. British Journal of Cancer 2015; 112(1): 69 doi: 10.1038/bjc.2014.536
|
55 |
Alessandro Cucchetti, Franco Trevisani, Anna Pecorelli, Virginia Erroi, Fabio Farinati, Francesca Ciccarese, Gian Lodovico Rapaccini, Mariella Di Marco, Eugenio Caturelli, Edoardo G. Giannini, Marco Zoli, Franco Borzio, Giuseppe Cabibbo, Martina Felder, Antonio Gasbarrini, Rodolfo Sacco, Francesco Giuseppe Foschi, Gabriele Missale, Filomena Morisco, Gianluca Svegliati Baroni, Roberto Virdone, Mauro Bernardi, Antonio D. Pinna. Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma. Journal of Hepatology 2014; 61(2): 333 doi: 10.1016/j.jhep.2014.03.037
|
56 |
Dan Shao, Jing Li, Xiao Zheng, Yue Pan, Zheng Wang, Ming Zhang, Qi-Xian Chen, Wen-Fei Dong, Li Chen. Janus “nano-bullets” for magnetic targeting liver cancer chemotherapy. Biomaterials 2016; 100: 118 doi: 10.1016/j.biomaterials.2016.05.030
|
57 |
Adnan Agha, Manuele Furnari, Rafaat Morched Chakik, Mamdouh M. Abdulhadi Ali, Dib Alsaudi, Mohammed Bazeed, Vincenzo Savarino, Edoardo G. Giannini. Hepatocellular Carcinoma Is the Most Frequent Final Diagnosis of Focal Liver Lesions Identified in a Cross-Sectional Evaluation of Patients with Chronic Liver Disease in Saudi Arabia. Journal of Cancer Research 2015; 2015: 1 doi: 10.1155/2015/492782
|
58 |
Yvonne Purcell, Pauline Copin, Luisa Paulatto, Romain Pommier, Valérie Vilgrain, Maxime Ronot. Hepatocellular carcinoma surveillance: Eastern and Western perspectives. Ultrasonography 2019; 38(3): 191 doi: 10.14366/usg.18043
|
59 |
Sheng-Hung Chen, Hsueh-Chou Lai, Wen-Pang Su, Jung-Ta Kao, Po-Heng Chuang, Wei-Fan Hsu, Hung-Wei Wang, Tsung-Lin Hsieh, Hung-Yao Chen, Cheng-Yuan Peng, Federico Ravaioli. Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis C. Canadian Journal of Gastroenterology and Hepatology 2022; 2022: 1 doi: 10.1155/2022/5201443
|
60 |
Sachin Shetty, Anushree U, Rajesh Kumar, Sanjay Bharati. Electrical conductivity spectra of hepatic tumors reflect hepatocellular carcinoma progression in mice. Biomedical Physics & Engineering Express 2020; 6(6): 065019 doi: 10.1088/2057-1976/abbbd5
|